Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands

Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 ( n = 20...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer (1990) 2004-12, Vol.40 (18), p.2781-2787
Hauptverfasser: Boerma, E.G., van Imhoff, G.W., Appel, I.M., Veeger, N.J.G.M., Kluin, Ph.M., Kluin-Nelemans, J.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2787
container_issue 18
container_start_page 2781
container_title European journal of cancer (1990)
container_volume 40
creator Boerma, E.G.
van Imhoff, G.W.
Appel, I.M.
Veeger, N.J.G.M.
Kluin, Ph.M.
Kluin-Nelemans, J.C.
description Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 ( n = 203). Detailed clinical data from two treatment protocols were compared: one for adults up to the age of 65 years ( n = 27) and one for children ( n = 80). All slides of the two clinical studies were centrally reviewed which included immunophenotyping and when necessary breakpoint analysis of MYC/8q24. Only cases with an unambiguous diagnosis of BL (classical and atypical BL) were accepted. The age distribution of BL-patients showed a bimodal distribution with a peak at the paediatric age and a steady increase after approximately 60 years of age. Most of the patients were males (89% for children and 78% for adults) and only male patients showed this bimodality. Children more often had extranodal disease (81% vs. 59%), whereas adults more often had nodal disease (89% vs. 53%). Based on epidemiology and clinical presentation, the concept that BL is one disease should be re-challenged.
doi_str_mv 10.1016/j.ejca.2004.09.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67136199</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0959804904007452</els_id><sourcerecordid>67136199</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-d38843c166944e6400154b1b8bf9d61e7830b87150b233b2c289d9aed4060d23</originalsourceid><addsrcrecordid>eNp9kM9u1DAQhy1URJfCC3CofCm3hHHsOLbUS1tBQargsnfLsSddb_Nna2cr9cY78IY8CU53pd44_TTSN78ZfYR8YlAyYPLLtsSts2UFIErQZY43ZMVUowtQdXVCVqBrXSgQ-pS8T2kLAI0S8I6csrpumJZsRR5vcfQYqR09tfdYROztjJ760HUYcXSYaBjp9T4-hHmm_fOw20yDpX9__6G4Cx6HMPXTfXC2f-lwfRhfBm9nS7s4DXS9QfoT5w3GPhPpA3nb2T7hx2OekfW3r-ub78Xdr9sfN1d3heOqmgvPlRLcMSm1ECgFAKtFy1rVdtpLho3i0KqG1dBWnLeVq5T22qIXIMFX_Ix8PtTu4vS4xzSbISSHff4Bp30ysmFcMq0zWB1AF6eUInZmF8Ng47NhYBbPZmsWz2bxbECbHHnp_Ni-bwf0rytHsRm4OAI2ZR1dtKML6ZWTXIJSy_XLA4dZxVPAaJILi3YfIrrZ-Cn8749_wlScQA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67136199</pqid></control><display><type>article</type><title>Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Boerma, E.G. ; van Imhoff, G.W. ; Appel, I.M. ; Veeger, N.J.G.M. ; Kluin, Ph.M. ; Kluin-Nelemans, J.C.</creator><creatorcontrib>Boerma, E.G. ; van Imhoff, G.W. ; Appel, I.M. ; Veeger, N.J.G.M. ; Kluin, Ph.M. ; Kluin-Nelemans, J.C.</creatorcontrib><description>Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 ( n = 203). Detailed clinical data from two treatment protocols were compared: one for adults up to the age of 65 years ( n = 27) and one for children ( n = 80). All slides of the two clinical studies were centrally reviewed which included immunophenotyping and when necessary breakpoint analysis of MYC/8q24. Only cases with an unambiguous diagnosis of BL (classical and atypical BL) were accepted. The age distribution of BL-patients showed a bimodal distribution with a peak at the paediatric age and a steady increase after approximately 60 years of age. Most of the patients were males (89% for children and 78% for adults) and only male patients showed this bimodality. Children more often had extranodal disease (81% vs. 59%), whereas adults more often had nodal disease (89% vs. 53%). Based on epidemiology and clinical presentation, the concept that BL is one disease should be re-challenged.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/j.ejca.2004.09.004</identifier><identifier>PMID: 15571961</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Burkitt lymphoma ; Burkitt Lymphoma - epidemiology ; Chi-Square Distribution ; Child ; Clinical presentation ; Cohort Studies ; Epidemiology ; Extranodal ; Female ; Gender ; Humans ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Netherlands - epidemiology ; Pharmacology. Drug treatments ; Registries ; Sex Distribution ; Tumors</subject><ispartof>European journal of cancer (1990), 2004-12, Vol.40 (18), p.2781-2787</ispartof><rights>2004 Elsevier Ltd</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-d38843c166944e6400154b1b8bf9d61e7830b87150b233b2c289d9aed4060d23</citedby><cites>FETCH-LOGICAL-c382t-d38843c166944e6400154b1b8bf9d61e7830b87150b233b2c289d9aed4060d23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0959804904007452$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16360889$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15571961$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boerma, E.G.</creatorcontrib><creatorcontrib>van Imhoff, G.W.</creatorcontrib><creatorcontrib>Appel, I.M.</creatorcontrib><creatorcontrib>Veeger, N.J.G.M.</creatorcontrib><creatorcontrib>Kluin, Ph.M.</creatorcontrib><creatorcontrib>Kluin-Nelemans, J.C.</creatorcontrib><title>Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 ( n = 203). Detailed clinical data from two treatment protocols were compared: one for adults up to the age of 65 years ( n = 27) and one for children ( n = 80). All slides of the two clinical studies were centrally reviewed which included immunophenotyping and when necessary breakpoint analysis of MYC/8q24. Only cases with an unambiguous diagnosis of BL (classical and atypical BL) were accepted. The age distribution of BL-patients showed a bimodal distribution with a peak at the paediatric age and a steady increase after approximately 60 years of age. Most of the patients were males (89% for children and 78% for adults) and only male patients showed this bimodality. Children more often had extranodal disease (81% vs. 59%), whereas adults more often had nodal disease (89% vs. 53%). Based on epidemiology and clinical presentation, the concept that BL is one disease should be re-challenged.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Burkitt lymphoma</subject><subject>Burkitt Lymphoma - epidemiology</subject><subject>Chi-Square Distribution</subject><subject>Child</subject><subject>Clinical presentation</subject><subject>Cohort Studies</subject><subject>Epidemiology</subject><subject>Extranodal</subject><subject>Female</subject><subject>Gender</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Netherlands - epidemiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Registries</subject><subject>Sex Distribution</subject><subject>Tumors</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM9u1DAQhy1URJfCC3CofCm3hHHsOLbUS1tBQargsnfLsSddb_Nna2cr9cY78IY8CU53pd44_TTSN78ZfYR8YlAyYPLLtsSts2UFIErQZY43ZMVUowtQdXVCVqBrXSgQ-pS8T2kLAI0S8I6csrpumJZsRR5vcfQYqR09tfdYROztjJ760HUYcXSYaBjp9T4-hHmm_fOw20yDpX9__6G4Cx6HMPXTfXC2f-lwfRhfBm9nS7s4DXS9QfoT5w3GPhPpA3nb2T7hx2OekfW3r-ub78Xdr9sfN1d3heOqmgvPlRLcMSm1ECgFAKtFy1rVdtpLho3i0KqG1dBWnLeVq5T22qIXIMFX_Ix8PtTu4vS4xzSbISSHff4Bp30ysmFcMq0zWB1AF6eUInZmF8Ng47NhYBbPZmsWz2bxbECbHHnp_Ni-bwf0rytHsRm4OAI2ZR1dtKML6ZWTXIJSy_XLA4dZxVPAaJILi3YfIrrZ-Cn8749_wlScQA</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>Boerma, E.G.</creator><creator>van Imhoff, G.W.</creator><creator>Appel, I.M.</creator><creator>Veeger, N.J.G.M.</creator><creator>Kluin, Ph.M.</creator><creator>Kluin-Nelemans, J.C.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041201</creationdate><title>Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands</title><author>Boerma, E.G. ; van Imhoff, G.W. ; Appel, I.M. ; Veeger, N.J.G.M. ; Kluin, Ph.M. ; Kluin-Nelemans, J.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-d38843c166944e6400154b1b8bf9d61e7830b87150b233b2c289d9aed4060d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Burkitt lymphoma</topic><topic>Burkitt Lymphoma - epidemiology</topic><topic>Chi-Square Distribution</topic><topic>Child</topic><topic>Clinical presentation</topic><topic>Cohort Studies</topic><topic>Epidemiology</topic><topic>Extranodal</topic><topic>Female</topic><topic>Gender</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Netherlands - epidemiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Registries</topic><topic>Sex Distribution</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boerma, E.G.</creatorcontrib><creatorcontrib>van Imhoff, G.W.</creatorcontrib><creatorcontrib>Appel, I.M.</creatorcontrib><creatorcontrib>Veeger, N.J.G.M.</creatorcontrib><creatorcontrib>Kluin, Ph.M.</creatorcontrib><creatorcontrib>Kluin-Nelemans, J.C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boerma, E.G.</au><au>van Imhoff, G.W.</au><au>Appel, I.M.</au><au>Veeger, N.J.G.M.</au><au>Kluin, Ph.M.</au><au>Kluin-Nelemans, J.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>40</volume><issue>18</issue><spage>2781</spage><epage>2787</epage><pages>2781-2787</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>Although Burkitt’s lymphoma (BL) is classified as one entity in the World Health Organisation (WHO) classification, we wondered whether BL should not be considered as a different disease in children compared with adults. Netherlands Cancer Registry (NCR) data were obtained from 1994 to 1998 ( n = 203). Detailed clinical data from two treatment protocols were compared: one for adults up to the age of 65 years ( n = 27) and one for children ( n = 80). All slides of the two clinical studies were centrally reviewed which included immunophenotyping and when necessary breakpoint analysis of MYC/8q24. Only cases with an unambiguous diagnosis of BL (classical and atypical BL) were accepted. The age distribution of BL-patients showed a bimodal distribution with a peak at the paediatric age and a steady increase after approximately 60 years of age. Most of the patients were males (89% for children and 78% for adults) and only male patients showed this bimodality. Children more often had extranodal disease (81% vs. 59%), whereas adults more often had nodal disease (89% vs. 53%). Based on epidemiology and clinical presentation, the concept that BL is one disease should be re-challenged.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>15571961</pmid><doi>10.1016/j.ejca.2004.09.004</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0959-8049
ispartof European journal of cancer (1990), 2004-12, Vol.40 (18), p.2781-2787
issn 0959-8049
1879-0852
language eng
recordid cdi_proquest_miscellaneous_67136199
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Biological and medical sciences
Burkitt lymphoma
Burkitt Lymphoma - epidemiology
Chi-Square Distribution
Child
Clinical presentation
Cohort Studies
Epidemiology
Extranodal
Female
Gender
Humans
Male
Medical sciences
Middle Aged
Multivariate Analysis
Netherlands - epidemiology
Pharmacology. Drug treatments
Registries
Sex Distribution
Tumors
title Gender and age-related differences in Burkitt lymphoma – epidemiological and clinical data from The Netherlands
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A22%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gender%20and%20age-related%20differences%20in%20Burkitt%20lymphoma%20%E2%80%93%20epidemiological%20and%20clinical%20data%20from%20The%20Netherlands&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Boerma,%20E.G.&rft.date=2004-12-01&rft.volume=40&rft.issue=18&rft.spage=2781&rft.epage=2787&rft.pages=2781-2787&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/j.ejca.2004.09.004&rft_dat=%3Cproquest_cross%3E67136199%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67136199&rft_id=info:pmid/15571961&rft_els_id=S0959804904007452&rfr_iscdi=true